SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-236306
Filing Date
2021-08-04
Accepted
2021-08-04 16:14:43
Documents
19
Period of Report
2021-08-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d171991d8k.htm   iXBRL 8-K 31507
2 EX-1.1 d171991dex11.htm EX-1.1 240443
3 EX-5.1 d171991dex51.htm EX-5.1 12391
4 EX-99.1 d171991dex991.htm EX-99.1 9485
5 EX-99.2 d171991dex992.htm EX-99.2 9939
9 GRAPHIC g171991dsp01.jpg GRAPHIC 3666
10 GRAPHIC g171991g0804134933182.jpg GRAPHIC 4955
11 GRAPHIC g171991g0804234506330.jpg GRAPHIC 1785
  Complete submission text file 0001193125-21-236306.txt   525049

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rna-20210803.xsd EX-101.SCH 2918
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20210803_lab.xml EX-101.LAB 18887
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20210803_pre.xml EX-101.PRE 11878
12 EXTRACTED XBRL INSTANCE DOCUMENT d171991d8k_htm.xml XML 3483
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 211144191
SIC: 2834 Pharmaceutical Preparations